• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

FDA approves Imagent

Article

Alliance Pharmaceutical will kick off its marketing campaign for ultrasound contrast agent Imagent June 9 at the annual meeting of the American Society of Echocardiography in Orlando. The commercial release follows recent FDA approval of the agent to

Alliance Pharmaceutical will kick off its marketing campaign for ultrasound contrast agent Imagent June 9 at the annual meeting of the American Society of Echocardiography in Orlando. The commercial release follows recent FDA approval of the agent to opacify the left ventricle in patients with suboptimal echocardiograms. Imagent, formerly known as Imavist, will be marketed by Alliance in partnership with Cardinal Health and inChord Communications. Imagent is manufactured from synthetic materials and packaged as a dry powder in a ready-to-use kit stored at room temperature. The powder is reconstituted with water to form an osmotically stabilized suspension of microscopic spheres, or microspheres, containing a perfluorochemical (perflexane) vapor and physiologic gases. Imagent is then injected intravenously into a patient undergoing a cardiac ultrasound exam.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.